 <h1>Mitigare Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>colchicine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about colchicine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Mitigare.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to colchicine: oral capsule, oral solution, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, colchicine (the active ingredient contained in Mitigare) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking colchicine:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>nausea</li>
<li>stomach pain</li>
<li>vomiting</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Black, tarry stools</li>
<li>blood in the urine or stools</li>
<li>burning, "crawling", or tingling feeling in the skin</li>
<li>difficulty with breathing when exercising</li>
<li>fever with or without chills</li>
<li>headache</li>
<li>large, hive-like swellings on the face, eyelids, mouth, lips, or tongue</li>
<li>muscle weakness</li>
<li>numbness in the fingers or toes (usually mild)</li>
<li>pain</li>
<li>peeling of the skin</li>
<li>pinpoint red spots on the skin</li>
<li>redness of the skin</li>
<li>skin rash or hives</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swelling</li>
<li>tenderness</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bleeding gums</li>
<li>chest pain</li>
<li>cough</li>
<li>dark urine</li>
<li>headache</li>
<li>high fever</li>
<li>muscle cramps, spasms, or stiffness</li>
<li>muscular pain, tenderness, or wasting</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>sensation of pins and needles</li>
<li>stabbing pain</li>
<li>swollen or painful glands</li>
<li>tightness in the chest</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking colchicine:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Bleeding</li>
<li>burning feeling in the stomach, throat, or skin</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>cold, clammy, pale skin</li>
<li>confusion</li>
<li>cough</li>
<li>diarrhea (severe or bloody)</li>
<li>dizziness</li>
<li>eye pain</li>
<li>fever</li>
<li>general feeling of illness</li>
<li>headache</li>
<li>irregular heartbeat</li>
<li>irregular, fast, slow, or shallow breathing</li>
<li>muscle weakness (very severe)</li>
<li>nausea, stomach pain, or vomiting (severe)</li>
<li>seizures</li>
<li>slow heart rate</li>
<li>sore throat</li>
<li>unusual tiredness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of colchicine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Hair loss or thinning of hair</li>
<li>loss of appetite</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Stomach bloating from increased gas</li>
<li>stomach cramping</li>
</ul><p>
<!-- end oral capsule, oral solution, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to colchicine: compounding powder, intravenous solution, oral capsule, oral liquid, oral tablet</i></p><h3>General</h3><p>The most common adverse reactions have included gastrointestinal symptoms and pharyngolaryngeal pain.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal events including diarrhea, nausea, vomiting, and abdominal pain are the most common adverse reactions reported with use of this drug.  These events are often the first signs of toxicity and may indicate the need for dose reduction or therapy discontinuation.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Diarrhea (23%)</p>
<p><b>Common</b> (1% to 10%): Abdominal cramping, abdominal pain, nausea, vomiting</p>
<p><b>Frequency not reported</b>: Lactose intolerance, gastrointestinal hemorrhage, paralytic ileus, stomatitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Agranulocytosis, thrombocytopenia, aplastic anemia</p>
<p><b>Postmarketing reports</b>: Myelosuppression, disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Rare</b> (less than 0.1%): Peripheral neuritis</p>
<p><b>Frequency not reported</b>: Sensory motor neuropathy<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Myopathy, rhabdomyolysis</p>
<p><b>Frequency not reported</b>: Elevated CPK, myotonia, muscle weakness, muscle pain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity including angioedema<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal damage, bladder spasm, anuria, oliguria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: elevated AST, elevated ALT, elevated alkaline phosphatase, hepatic damage<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngolaryngeal pain</p>
<p><b>Postmarketing reports</b>: Adult respiratory distress syndrome<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Delayed corneal wound healing<sup>[Ref]</sup></p><p>There have been reports of corneal ulcers refractory to conventional treatment and delayed corneal wound healing following strabismus surgery in patients receiving colchicine.  Discontinuation of colchicine therapy resulted in satisfactory wound healing within several days.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (less than 0.1%): Alopecia</p>
<p><b>Very rare</b> (less than 0.01%): Nonthrombocytopenic purpura rashes, rashes, urticaria, dermatoses, dermatitis</p>
<p><b>Frequency not reported</b>: Maculopapular rash<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Hypothyroidism<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Azoospermia, oligospermia</p>
<p><b>Frequency not reported</b>: Amenorrhea, dysmenorrhea, hematuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Loss of appetite<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Mitigare (colchicine)." Hikma Americas, Inc, Memphis, TN. </p><p id="ref_2">2. "Product Information. Colcrys (colchicine)." AR Scientific Inc, Philadelphia, PA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Can Colchicine be used to treat COVID-19 (coronavirus)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Mitigare (colchicine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Drug class: antigout agents</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Mitigare &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Colcrys, Gloperba</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Gout, Acute</li>
<li>Gout, Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to colchicine: compounding powder, intravenous solution, oral capsule, oral liquid, oral tablet</i></p><h3>General</h3><p>The most common adverse reactions have included gastrointestinal symptoms and pharyngolaryngeal pain.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal events including diarrhea, nausea, vomiting, and abdominal pain are the most common adverse reactions reported with use of this drug.  These events are often the first signs of toxicity and may indicate the need for dose reduction or therapy discontinuation.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Diarrhea (23%)</p><p><b>Common</b> (1% to 10%): Abdominal cramping, abdominal pain, nausea, vomiting</p><p><b>Frequency not reported</b>: Lactose intolerance, gastrointestinal hemorrhage, paralytic ileus, stomatitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Agranulocytosis, thrombocytopenia, aplastic anemia</p><p><b>Postmarketing reports</b>: Myelosuppression, disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Rare</b> (less than 0.1%): Peripheral neuritis</p><p><b>Frequency not reported</b>: Sensory motor neuropathy<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Myopathy, rhabdomyolysis</p><p><b>Frequency not reported</b>: Elevated CPK, myotonia, muscle weakness, muscle pain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity including angioedema<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal damage, bladder spasm, anuria, oliguria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: elevated AST, elevated ALT, elevated alkaline phosphatase, hepatic damage<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngolaryngeal pain</p><p><b>Postmarketing reports</b>: Adult respiratory distress syndrome<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Delayed corneal wound healing<sup>[Ref]</sup></p><p>There have been reports of corneal ulcers refractory to conventional treatment and delayed corneal wound healing following strabismus surgery in patients receiving colchicine.  Discontinuation of colchicine therapy resulted in satisfactory wound healing within several days.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (less than 0.1%): Alopecia</p><p><b>Very rare</b> (less than 0.01%): Nonthrombocytopenic purpura rashes, rashes, urticaria, dermatoses, dermatitis</p><p><b>Frequency not reported</b>: Maculopapular rash<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Hypothyroidism<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Azoospermia, oligospermia</p><p><b>Frequency not reported</b>: Amenorrhea, dysmenorrhea, hematuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Loss of appetite<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Mitigare (colchicine)." Hikma Americas, Inc, Memphis, TN. </p><p id="ref_2">2. "Product Information. Colcrys (colchicine)." AR Scientific Inc, Philadelphia, PA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Can Colchicine be used to treat COVID-19 (coronavirus)?</li>
</ul><h2>More about Mitigare (colchicine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Drug class: antigout agents</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Mitigare &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Gout, Acute</li>
<li>Gout, Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>